International Patent: ANTIBODY SPECIFICALLY BINDING TO LIPOCORTIN 1 AND USE THEREOF

GENEVA, July 31 -- TRIOAR INC. filed a patent application (KR2026/001012) for “ANTIBODY SPECIFICALLY BINDING TO LIPOCORTIN 1 AND USE THEREOF”. With publication no. WO/2026/160780, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/18

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....